Related Experiment Video
Updated: Apr 18, 2026
07:44
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
7.1K
Primary Gastric Burkitt's Lymphoma
Swarupa Mitra1, Anurag Mehta2, Sunil Kumar Gupta3
1Departments of Radiation Oncology, New Delhi, India.
Rare Tumors
|January 9, 2015
Summary
Primary gastric Burkitt's lymphoma (BL), a rare cancer, is aggressive. This case report details a stage IV gastric BL in an HIV-negative male who unfortunately succumbed to the disease after initial chemotherapy.
Area of Science:
- Oncology
- Gastroenterology
- Hematology
Background:
- Non-Hodgkin's lymphoma (NHL) can manifest in the gastrointestinal tract, with gastric lymphomas being more prevalent than intestinal lymphomas.
- Burkitt's lymphoma (BL) is a highly aggressive B-cell lymphoma, endemic in Africa but also occurring globally.
- Primary gastric BL is exceptionally rare, with fewer than 50 cases documented worldwide.
Observation:
- This report presents a case of a young, HIV-negative male diagnosed with stage IV primary gastric BL.
- The patient was initiated on palliative chemotherapy for his advanced disease.
Findings:
- Despite palliative chemotherapy, the patient experienced rapid disease progression.
- The patient succumbed to the disease after the first cycle of chemotherapy, highlighting the aggressive nature of this rare condition.
Implications:
- This case underscores the extreme rarity and aggressive behavior of primary gastric BL, even in HIV-negative individuals.
- It emphasizes the challenges in managing advanced-stage gastric BL and the need for further research into effective therapeutic strategies.
- The case contributes to the limited global data on primary gastric BL, particularly in non-endemic settings.
Related Concept Videos
01:26Gastritis II: Pathophysiology
2
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
2
01:27Peptic Ulcer
37
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
37
01:11Pyloric Obstruction
2
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
2
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
872
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
872
01:30Peptic Ulcer Disease I: Introduction
1.2K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K
01:23Gastritis III: Clinical Manifestations and Management
1.8K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.8K